Invention Grant
- Patent Title: Modulation of PTPRA to treat arthritis
-
Application No.: US15509829Application Date: 2015-09-09
-
Publication No.: US10604585B2Publication Date: 2020-03-31
- Inventor: Nunzio Bottini , Gary Firestein , Stephanie Stanford
- Applicant: La Jolla Institute for Allergy & Immunology , The Regents of the University of California
- Applicant Address: US CA La Jolla US CA Oakland
- Assignee: La Jolla Institute for Allergy & Immunology,The Regents of the University of California
- Current Assignee: La Jolla Institute for Allergy & Immunology,The Regents of the University of California
- Current Assignee Address: US CA La Jolla US CA Oakland
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- International Application: PCT/US2015/049228 WO 20150909
- International Announcement: WO2016/040510 WO 20160317
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C07K16/40 ; C12N15/113 ; G01N33/50
Abstract:
Presented is a method for treating inflammation and autoimmune diseases through the use of a phosphatase rheumatoid arthritis (PT-PRA) antagonist.
Public/Granted literature
- US20170247469A1 MODULATION OF PTPRA TO TREAT ARTHRITIS Public/Granted day:2017-08-31
Information query
